Message From The Cancer Centre Leaders


 

Thanks to extraordinary advances we have made across the spectrum of cancer research, patient care and education, there are many reasons to be optimistic. Survival rates for Canadians diagnosed with cancer have climbed from 56% to 63% over the last decade.[1]  Quality of life has also improved substantially thanks to the increasing preservation of healthy tissue through targeted treatments, as well as survivorship programs and unprecedented forays into interdisciplinary psychosocial research.
 
We are optimistic because, at the frontiers of cancer research, we are seeing significant change.
 
At Princess Margaret Cancer Centre, breakthrough discovery and compassionate care go hand-in-hand. Our clinician scientists provide valuable clinical insights to our researchers, who then witness the impact of their research discoveries on patient care. It is this union between research and clinical care that makes us one of the top 5 cancer research centres in the world. Another key component of our research success is that we are Canada’s only comprehensive research and cancer treatment centre.
 
We have one of the largest and most highly skilled cancer clinical trials programs in the world. With over 700 active clinical trials and 1 in 6 patients participating in a clinical trial, The Princess Margaret has made treatment discoveries that are changing the standard of care. We are also leading the way in Immunotherapy, a new area of cancer research that uses the body’s own immune system to fight cancer.
 
Because of this unique environment, The Princess Margaret continues to attract and retain outstanding talent from other leading cancer institutions around the globe. As part of University Health Network (UHN), The Princess Margaret welcomed newly appointed UHN President & CEO, Dr. Kevin Smith, in May of 2018. Dr. Smith is well known for his contribution to the healthcare system both provincially and nationally and was formerly President and CEO of St. Joseph’s Health System in Hamilton and Chief Executive Officer of Niagara Health System.

Beyond our world-class staff, several newly established centres, collaborations and research breakthroughs are making our vision—Conquer Cancer In Our Lifetime—a reality. We have significantly expanded the Blood and Marrow Transplant Program and have launched the first phase of a space transformation, which will renovate and revitalize our main floor and clinics and further facilitate clinical research. We also grew our international partnerships and took part in the World Cancer Congress in Malaysia.  We also expanded our global partnerships by signing a memorandum of understanding with the German Cancer Research Centre. By facilitating the transfer of knowledge within The Princess Margaret and on a global basis, we help ensure the highest standards of care are available to the widest range of patients.
 
For decades, Princess Margaret researchers have had a profound impact on the way cancer is detected, diagnosed, targeted and supported.  To accommodate our growing research enterprise, we expanded our campus to include the Princess Margaret Cancer Research Tower.  Advancing our knowledge, making new discoveries and translating this into the clinic to improve patient outcomes is embedded in The Princess Margaret’s DNA. 
 
Though our work is far from over, we remain optimistic because we have the expertise to lay the groundwork for important progress in the years ahead. With the support and generosity of our extraordinary donors, event participants, lottery supporters and volunteers, we will continue to advance cancer research to improve care for patients at The Princess Margaret, across Canada and beyond.
 
Thank you for your support,
    
Dr. Mary Gospodarowicz
Medical Director
 
Dr. Mitsu Ikura 
Interim Research Director